Community Practice Connections™: Medical Crossfire®: Foundations in Outpatient Administration of Infused Therapies for COVID-19: Keeping Patients Out of the Hospital

Community Practice Connections™: Medical Crossfire^®: Foundations in Outpatient Administration of Infused Therapies for COVID-19: Keeping Patients Out of the Hospital

 
Faculty Presenters

Raymund R. Razonable, MD
Professor of Medicine
Mayo Clinic
Rochester, Minnesota

P. Brandon Bookstaver, PharmD, BCPS, FCCP, FIDSA
Associate Professor
Director, Residency and Fellowship Training
Department of Clinical Pharmacy and Outcomes Sciences
University of South Carolina College of Pharmacy
Infectious Diseases Pharmacist
Director, ID PGY2 Residency and Clinical Fellowship Program
Prisma Health Midlands
Columbia, South Carolina

Jason C. Gallagher, PharmD, FCCP, FIDP, FIDSA, BCPS
Clinical Professor
Department of Pharmacy Practice
Temple University
Clinical Pharmacy Specialist, Infectious Diseases
Temple University Hospital
Philadelphia, Pennsylvania

Jerod Nagel, PharmD, BCIDP
Pharmacy Lead, Infectious Diseases and Antimicrobial Stewardship
Clinical Assistant Instructor
Director, Infectious Diseases Residency
Michigan Medicine
University of Michigan, College of Pharmacy
Ann Arbor, Michigan
 
Program Description
COVID-19 is a rapidly evolving global public health threat that has affected virtually all aspects of patient care, including the treatment of patients with other acute and chronic diseases. The cause of COVID-19 is SARS-CoV-2, a β-coronavirus. Recent research efforts have focused on the development of vaccines, new antiviral agents, convalescent plasma infusions, and monoclonal antibodies for either the prevention or treatment of COVID-19. Neutralizing monoclonal antibodies to SARS-CoV-2 have the potential for both therapeutic and prophylactic applications. Neutralizing monoclonal antibodies directed against SARS-CoV-2 have been developed and are under investigation in clinical trials. In addition, several of these drugs have recently been approved by the United States Food and Drug Administration (FDA) and drugs made available under FDA emergency use authorization (EUA).

This Community Practice Connection™ program provides an in-depth review of some of the key highlights from the Medical Crossfire^®: Foundations in Outpatient Administration of Infused Therapies for COVID-19: Keeping Patients out of the Hospital held in February and March 2021. This unique and engaging multi-media activity is ideal for the community-based clinician and focuses on the practical aspects of managing patients with SARS-CoV-2 infection, putting recent clinical trial data into clinical context. The program is designed for those who did not attend the live meeting and to help reinforce learnings for those who did.

Target Audience: Physicians, nurses, and pharmacists who specialize in administering infused therapies in an outpatient setting
Type of Activity: Application
Release date: May 11, 2021
Expiration date: May 11, 2022
Time to complete activity: 1.0 hour
Fee: Free

Educational Objectives
At the completion of this activity, participants will be able to:

• Discuss best practices for administration of infused therapies in patients with confirmed COVID-19 infection at elevated risk of hospitalization
• Identify signs and symptoms of potential adverse reactions to infused neutralizing antibody therapy in patients with confirmed with COVID-19 infection
• Incorporate best practices for patient counseling and education regarding the administration of infused therapies in patients with confirmed COVID-19 infection

Pharmacy Times Continuing Education™ is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This activity is approved for 1.0 contact hour (0.10 CEU) under the ACPE universal activity number 0290-0000-21-186-H01-P. The activity is available for CE credit through May 11, 2022.


Physicians and nurses, please visit https://www.gotoper.com/online-cme-activities/cpc/cpc-mxf21covid to complete this activity for ACCME credit.

Instructions for Completing the Activity and Receiving CPE Credit
To receive CPE credit, participants must complete the pretest, review the activity in its entirety, complete the posttest, and complete the online activity evaluation. After successful completion of the online activity evaluation, you can submit your credit to CPE Monitor. You may view your credit within 48 hours at www.mycpemonitor.net. All participants must request credit before the activity expiration date. CE credit will not be issued after this date.
 

---

Disclosures

Raymund R. Razonable, MD, has the following relevant financial relationships with commercial interests to disclose:
Grant/Research Support: Regeneron Pharmaceuticals (research grants to the institution), Hoffmann-La Roche

P. Brandon Bookstaver, PharmD, BCPS, FCCP, FIDSA, has the following relevant financial relationships with commercial interests to disclose:
Consultant: Grifols, BPS
Other: Other: Research advisor for Kedrion Biopharma (rabies immunoglobulin research)

Jason C. Gallagher, PharmD, FCCP, FIDP, FIDSA, BCPS, and Jerod Nagel, PharmD, BCIDP, have no relevant financial relationships with commercial interests to disclose.

Pharmacy Times Continuing Education™ Planning Staff – Jim Palatine, RPh, MBA; Maryjo Dixon, RPh; Crissy Wilson; Susan Pordon; and Brianna Winters have no relevant financial relationships with commercial interests to disclose.

An anonymous peer reviewer is used as part of content validation and conflict resolution. The peer reviewer has no relevant financial relationships with commercial interests to disclose.

Educational Disclaimer
CPE activities are offered solely for educational purposes and do not constitute any form of professional advice or referral. Discussions concerning drugs, dosages, and procedures may reflect the clinical experience of the author(s) or they may be derived from the professional literature or other sources and may suggest uses that are investigational in nature and not approved labeling or indications. Participants are encouraged to refer to primary references or full prescribing information resources.

For questions about this internet CPE activity, please contact:
[email protected]
Privacy Policy and Terms of Use Information:
www.pharmacytimes.org/terms